Search Results for: eteplirsen

Exondys 51 (eteplirsen)

Exondys 51 (eteplirsen), developed by Sarepta Therapeutics, is the first treatment approved by the U.S. Food and Drug Administration (FDA) for a specific group of patients with Duchenne muscular ... Read more